Home
About
- - About AUSA
    AUSA was spun off in 2018 from Aurora Cannabis, one of the leading global cannabis companies, creating an entity permitted to invest in and operate U.S. based cannabis assets. Originally an investment company, AUSA has successfully pivoted to become an operating company.
Investor Information
- - Investor Information
    AUSA’s mission is to become the most recognized and highly regarded global cannabis brand.
News & Events
- - News & Events
    As a leading multi-state operating company with award-winning brands across America, AUSA will be releasing timely news updates, media communiqués and conducting influential events which complement and advance our corporate mission. We use our News & Events platform to showcase our successes as well as share important knowledge about AUSA, our top decision-makers and the cannabis industry.
Contact

January 2019

January 14, 2019

Australis Capital Invests in Folium Biosciences a Global Leader in Non-Psychoactive Cannabinoid Production

LAS VEGAS, Jan. 14, 2019 /CNW/ - Australis Capital Inc. (CSE: AUSA) ("Australis" or the "Company") is pleased to announce the Company has invested $3,000,000 USD in Folium Biosciences ("Folium"), the largest vertically integrated producer, manufacturer, and distributor of hemp-derived phytocannabinoids in the United States. Folium also owns and operates the largest phytocannabinoid extraction and purification facility in the United States, with plans for a new pharmaceutical division and the completion of their Canadian facility in 2019.